Aspire Biopharma Holdings annual total assets
2021
2022
2023
2024
2025
Aspire Biopharma Holdings Total Assets Growth & History (ASBP)
Aspire Biopharma Holdings's total assets was $1.3M for fiscal 2025.
View full Aspire Biopharma Holdings company overviewAspire Biopharma Holdings annual total assets history
| Fiscal year | Period ended | Total assets | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $1.3M | $1.2M | +786.66% |
| 2024 | 2024-12-31 | $147,989 | −$19.8M | −99.26% |
| 2023 | 2023-12-31 | $20.0M | −$280.2M | −93.34% |
| 2022 | 2022-12-31 | $300.2M | $299.9M | +102273.98% |
| 2021 | 2021-12-31 | $293,221 | — | — |
Aspire Biopharma Holdings quarterly total assets
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Total assets | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $13.5M | $12.6M | +1268.53% |
| Q1 2026 | 2026-03-31 | $7.1M | $5.2M | +262.10% |
| Q4 2025 | 2025-12-31 | $1.3M | $1.2M | +786.66% |
| Q3 2025 | 2025-09-30 | $2.4M | −$4.3M | −63.93% |
| Q2 2025 | 2025-06-30 | $989,422 | −$5.9M | −85.59% |
| Q1 2025 | 2025-03-31 | $2.0M | −$18.2M | −90.27% |
| Q4 2024 | 2024-12-31 | $147,989 | −$19.8M | −99.26% |
| Q3 2024 | 2024-09-30 | $6.7M | −$13.2M | −66.51% |
| Q2 2024 | 2024-06-30 | $6.9M | −$13.7M | −66.60% |
| Q1 2024 | 2024-03-31 | $20.2M | −$282.9M | −93.34% |
| Q4 2023 | 2023-12-31 | $20.0M | −$280.2M | −93.34% |
| Q3 2023 | 2023-09-30 | $19.9M | −$277.9M | −93.32% |
| Q2 2023 | 2023-06-30 | $20.6M | −$276.2M | −93.07% |
| Q1 2023 | 2023-03-31 | $303.1M | $6.6M | +2.23% |
| Q4 2022 | 2022-12-31 | $300.2M | $299.9M | +102273.98% |
| Q3 2022 | 2022-09-30 | $297.8M | — | — |
| Q2 2022 | 2022-06-30 | $296.7M | — | — |
| Q1 2022 | 2022-03-31 | $296.5M | — | — |
| Q4 2021 | 2021-12-31 | $293,221 | — | — |
Aspire Biopharma Holdings total assets trends
Between the periods ended 2021-12-31 and 2025-12-31, Aspire Biopharma Holdings's total assets increased from $293,221 to $1.3M, a change of $1.0M. The latest reported quarter, Q2 2026, shows $13.5M.
About the metric
What total assets mean
Total assets are the resources a company controls at a reporting-period end, including cash, investments, receivables, inventory, property, intangible assets, and other reported assets. The composition of assets differs substantially by industry.
Calculation and source
SEC-reported total assets
TickerStat uses total assets reported in company SEC filings. When a filer provides the equivalent balance-sheet total as liabilities and equity, that reported amount is used because total assets must equal total liabilities plus equity. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Aspire Biopharma Holdings source filings ↗